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Abstract
C11H19N3S, monoclinic, C2/m (no. 12), a= 10.789(3) Å,
b= 6.959(3) Å, c= 15.196(4) Å, β= 96.843(13)°, V =
1132.7(6) Å3, Z = 4, Rgt(F)=0.0568, wRref(F2)=0.1414,
T = 293(2) K.
CCDC no.: 1833408
The molecular structure is shown in the figure. Table 1 con-
tains crystallographic data and Table 2 contains the list of
the atoms including atomic coordinates and displacement
parameters.
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Table 1: Data collection and handling.
Crystal: Colourless plate
Size: 0.48×0.42×0.05 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.26 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θmax, completeness: 25.0°, >99%
N(hkl)measured, N(hkl)unique, Rint: 7771, 1093, 0.135
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 762
N(param)refined: 89
Programs: Bruker [1], SHELX [2, 3],
WinGX/ORTEP [4]
Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
S1 0.53346(10) 0.500000 0.36464(7) 0.0370(4)
N1 0.7848(3) 0.500000 0.3712(2) 0.0301(8)
H1N 0.854(2) 0.500000 0.405(2) 0.036*
N2 0.7036(3) 0.500000 0.5022(2) 0.0435(10)
H2N 0.640(3) 0.500000 0.531(3) 0.052*
N3 0.8264(4) 0.500000 0.5461(2) 0.0456(10)
H3N 0.839(3) 0.393(3) 0.574(2) 0.055*
C1 0.7962(3) 0.500000 0.2747(2) 0.0232(9)
C2 0.9361(3) 0.500000 0.2662(3) 0.0302(10)
H2Aa 0.974727 0.612885 0.295235 0.036*
H2Ba 0.974727 0.387115 0.295235 0.036*
C3 0.9571(3) 0.500000 0.1685(3) 0.0309(10)
H3 1.046913 0.500002 0.163813 0.037*
C4 0.8977(2) 0.3206(4) 0.1231(2) 0.0366(8)
H4A 0.911152 0.319594 0.061148 0.044*
H4B 0.935789 0.206168 0.151022 0.044*
C5 0.7583(2) 0.3213(4) 0.13097(18) 0.0318(7)
H5 0.719989 0.206382 0.102037 0.038*
C6 0.7381(2) 0.3201(4) 0.22922(17) 0.0292(7)
H6A 0.649435 0.316663 0.234550 0.035*
H6B 0.776195 0.206288 0.257743 0.035*
C7 0.6976(4) 0.500000 0.0865(3) 0.0322(10)
H7A 0.608904 0.499999 0.091880 0.039*
H7B 0.708112 0.500000 0.024033 0.039*
C8 0.6833(4) 0.500000 0.4131(2) 0.0290(10)
aOccupancy: 0.5.
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Source of material
Hydrazine hydrate (98%, 5 mL) was added to a hot solution
of 1-adamantyl isothiocyanate (1.93 g, 0.01 mol) in ethanol
(10 mL) and the mixture was heated under reflux with stir-
ring for 1 h. On cooling, the precipitated crude product was
filtered, washed with cold ethanol, dried and crystallised
from ethanol to yield 2.12 g (94%) of the title compound
as transparent plates. M.pt: 468–470 K. 1H NMR (DMSO-d6,
700.17 MHz): δ 8.40 (s, 1H, NH), 7.43 (t, 1H, NH, J = 10.5 Hz),
4.50 (d, 2H, NH2, J = 10.5 Hz), 2.51 (s, 6H, Adamantane-H),
2.05 (s, 3H, Adamantane-H), 1.63 (s, 6H, Adamantane-H).
13C NMR (DMSO-d6, 176.08 MHz): δ 179.55 (C=S), 29.47, 36.43,
41.85, 50.37 (Adamantane-C). ESI-MS: m/z 224.0 [M—H]−,
226.0 [M+H]+.
Experimental details
The C-bound H atoms were geometrically placed (C—H=
0.97–0.98 Å) and refined as riding with U iso(H)= 1.2Ueq(C).
The N-bound H atoms were located from a difference Fourier
map and refinedwith N—H=0.88 ± 0.01 Å, andwithU iso(H)
set to 1.2Ueq(N).
Comment
The diverse pharmacological activities of adamantane-
based drugs are well known. Early examples include aman-
tadine, which was approved as a potent drug against
Influenza A viral infections, and tromantadine, which is
currently used against herpes simplex skin viral infections
[5]. More recently, 3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)
adamantane-1-carboxamide (ABC294640) was approved
as an anti-cancer drug for the treatment of patients with
advanced solid tumours in response to its ability to act
as a sphingosuine kinase inhibitor [6]. In connection with
the present study, describing the investigation of a hybrid
adamantane-thiosemicarbazide species, thiosemicarbazide
and thiosemicarbazone derivatives have also been reported
to possess marked chemotherapeutic properties [7, 8]. The
title compound, 4-(1-adamantyl)-3-thiosemicarbazide was
previously isolated as a minor by-product during the reac-
tion of N-(adamantan-1-yl)-4-ethoxycarbonylpiperidine-1-
carbothioamide with excess hydrazine hydrate, in ethanol,
at reflux temperature [9]. In connection of on-going biolog-
ical [10, 11] and crystallographic [12, 13] studies of related
species, the present investigation describes the synthesis and
single-crystal X-ray structural analysis of the title structure (I).
The molecular structure (I) is shown in the Figure (35%
probability ellipsoids with unlabelled atoms related by the
symmetry operation x, 1 − y, z). The molecule has crys-
tallographically imposed mirror symmetry, with the mirror
plane bisecting the adamantyl residue and contains the
N(H)C(=S)N(H)N atoms of the thiosemicarbazide residue.
The C-bound amine-hydrogen atom is antiwith respect to the
thione bond and the N-amide is syn, so the terminal amine
group is anti to the thione bond. The C8—N1 [1.330(5) Å], C8—
S1 [1.695(4) Å], C8—N2 [1.345(5) Å] and N2—N3 [1.411(5) Å]
bond lengths follow our expectations. Simiarly, the bond
angles about the C8 atom generally follow the forecast, with
those involving the doubly-bonded S1 atom, i.e. N1—C8—S1
[126.1(3)°] and N2—C8—S1 [118.0(3)°], being wider than that
subtended by the N atoms, i.e. N1—C8—N2 is 116.0(3)°. It is
likely that the relatively narrow N2—C8—S1 angle is the result
of the steric demand of the proximate adamantyl residue as
seen in the C1—N1—C8 angle of 130.0(3)°.
The most closely related structure in the literature is that
where the N1-substituted adamantyl group is replaced by a
methyl group [14]. Alternatively, when the adamantyl remains
intact, the closest structure resembling (I) is one where the
terminal NH2 residue is substituted by a phenyl group [15]. In
both instances, there is no change of conformation, i.e. the
anti/syn relationships, about the NC(=S)N chromophore.
Despite their being four acidic H atoms in the
molecule of (I), besides an intramolecular N1—H1n· · ·N3
hydrogen bond [N1—H1n· · ·N3: H1· · ·N3= 2.20(3) Å,
N1· · ·N3= 2.642(4) Å with angle at H1n= 112(2)°], the only
intermolecular contact involving these potential donors
is a N2—H2n· · · S1 hydrogen bond. These hydrogen bonds
occur between molecules related by 2-fold symmetry [N2—
H2n· · · S1i: H2n· · · S1i = 2.59(4) Å, N2· · · S1i = 3.445(4) Å with
angle at H2n= 173(4)° for symmetry operation (i): 1 − x, y,
1 − z]. The resultant dimeric aggregates assemble without
directional interactions between them. Globally, the dimers
are arranged into layer in the ac-plane and stack along the
b-axis in an · · ·ABA· · · fashion.
In order to gain greater insight into the molecular pack-
ing of (I), especially in the absence of significant directional
interactions between dimeric aggregates, the Hirshfeld sur-
faces were calculated along with the full and decomposed
two-dimensional fingerprint plots. This was accomplished
with Crystal Explorer 17 [16] following literature protocols [17].
There are significant contributions to the Hirshfeld surface by
S· · ·H/H· · ·H[16.0%], C· · ·H/H· · ·C [3.9%] andN· · ·H/H· · ·N
[3.3%]. However, reflecting the lack of directional interactions
in the molecular packing, the most dominant contrbutions to
the surface contacts are from H· · ·H contacts, at 76.8%.
Acknowledgements: Crystallographic research at Sunway
University is supported by Sunway University Sdn Bhd (Grant
no. STR-RCTR-RCCM-001-2019).
References
1. Bruker. SADABS, APEX2 and SAINT. Bruker AXS Inc., Madison,
WI, USA (2014).
Al-Mutairi et al.: C11H19N3S | 1117
2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr.
A64 (2008) 112–122.
3. Sheldrick, G. M.: Crystal structure refinement with SHELXL.
Acta Crystallogr. C71 (2015) 3–8.
4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update.
J. Appl. Crystallogr. 45 (2012) 849–854.
5. Wanka, L.; Iqbal, K.; Schreiner, P. R.: The lipophilic bullet hits
the targets: medicinal chemistry of adamantane derivatives.
Chem. Rev. 113 (2013) 3516–3604.
6. Britten, C. D.; Garrett-Mayer, E.; Chin, S. H.; Shirai, K.;
Ogretmen, B.; Bentz, T. A.; Brisendine, A.; Anderton, K.;
Cusack, S. L.; Maines, L. W.; Zhuang, Y.; Smith, C. D.; Thomas,
M. B.: A phase I study of ABC-294640, a first-in-class sphingo-
sine kinase-2 inhibitor, in patients with advanced solid tumors.
Clin. Cancer Res. 23 (2017) 4642–4650.
7. De Aquino, T. M.; Liesen, A. P.; da Silva, R. E. A.; Lima, V. T.;
Carvalho, C. S.; de Faria, A. R.; de Araujo, J. M.; de Lima, J. G.;
Alves, A. J.; de Melo, E. J. T.; Goes, A. J. S.: Synthesis, anti-
Toxoplasma-gondii and antimicrobial activities of benzalde-
hyde 4-phenyl-3-thiosemicarbazones and 2-[(phenymethylene)
hydrazono]-4-oxo-3- phenyl-5-thiazolidine acetic acids. Bioorg.
Med. Chem. 16 (2008) 446–456.
8. Hu, W.-X.; Zhou, W.; Xia, C.-N.; Wen, X.: Synthesis and anti-
cancer activity of thiosemicarbazones. Bioorg. Med. Chem.
Lett. 16 (2006) 2213–2218.
9. Al-Abdullah, E. S.; Al-Tuwaijri, H. M.; Hassan, H. M.;
Al-Alshaikh, M. A.; Habib, E. E.; El-Emam, A. A.: Synthesis,
antimicrobial and hypoglycemic activities of novel N-(1-
adamantyl)carbothioamide derivatives. Molecules 20 (2015)
8125–8143.
10. El-Emam, A. A.; Al-Tamimi, A.-M. S.; Al-Omar, M. A.;
Alrashood, K. A.; Habib, E. E.: Synthesis and antimicrobial
activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-
1,2,4-triazoline-3-thiones. Eur. J. Med. Chem. 68 (2013)
96–102.
11. Al-Wahaibi, L. H.; Hassan, H. M.; Abo-Kamar, A. M.;
Ghabbour, H. A.; El-Emam, A. A.: Adamantane-isothiourea
hybrid derivatives: synthesis, characterization, in vitro antimi-
crobial, and in vivo hypoglycemic activities. Molecules 22
(2017) article no. 710.
12. Al-Ghulikah, H. A.; Ghabbour, H. A.; Tiekink, E. R. T.; El-Emam,
A. A.: Crystal structure of 4-bromobenzyl (Z)-N-(adamantan-
1-yl)morpholine-4-carbothioimidate, C22H29BrN2OS.
Z. Kristallogr. NCS 234 (2019) 1001–1003.
13. Al-Wahaibi, L. H.; Al-Shaalan, N. H.; Ghabbour, H. A.;
Tiekink, E. R. T.; El-Emam, A. A.: Crystal structure of
3,5-bis(trifluoromethyl)benzyl (Z)-N′-(adamantan-1-yl)-
4-phenylpiperazine-1-carbothioimidate, C30H33F6N3S.
Z. Kristallogr. NCS 234 (2019) 1009–1012.
14. Castiñeiras, A.; Bermejo, E.; Valdes-Martínez, J.; Espinosa-
Pérez, G.; West, D. X.: Structural study of two N(3)-substituted
thiosemicarbazide copper(II) complexes. J. Mol. Struct. 522
(2000) 271–278.
15. Al-Wahaibi, L. H.; Ghabbour, H. A.; Mostafa, G. A. E.;
Almutairi, M. S.; El-Emam, A. A.: Crystal structure of 1-
(adamantan-1-yl)-3-phenylthiourea, C17H22N2S. Z. Kristallogr.
NCS 231 (2016) 593–595.
16. Turner, M. J.; Mckinnon, J. J.; Wolff, S. K.; Grimwood, D. J.;
Spackman, P. R.; Jayatilaka, D.; Spackman, M. A.: Crystal
Explorer v17. The University of Western Australia, Australia,
2017.
17. Tan, S. L.; Jotani, M. M.; Tiekink, E. R. T.: Utilizing Hirshfeld sur-
face calculations, non-covalent interaction (NCI) plots and the
calculation of interaction energies in the analysis of molecular
packing. Acta Crystallogr. E75 (2019) 308–318.
